1st Quarter - Amendment

OMNICARE, INC. for OMNICARE INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 15, 2013 $100,000 Replaced
1st Quarter - Amendment (this page) Apr 29, 2013 $100,000 Replaced
1st Quarter - Amendment Apr 30, 2013 $100,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Support of federal auditing standards of downstream of Medicare drug benefit plan sponsors (no legislation introduced).

LobbyistCovered position, as disclosed
PAUL BALDWIN —
JAMES FLOOD New —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Drug Enforcement Administration proposed rule on disposal of controlled substances in long term care facilities.

LobbyistCovered position, as disclosed
PAUL BALDWIN —
JAMES FLOOD New —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.